Picture of Larkberget AB logo

LARK — Larkberget AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Combigene - New Preclinical Research Results In Epilepsy Project

Sept 30 (Reuters) - Combigene AB  COMBI.ST :
    * ANNOUNCES NEW PRECLINICAL RESEARCH RESULTS IN EPILEPSY
PROJECT
    * RESULTS SHOW ANTIEPILEPTIC EFFECTS, ALTHOUGH A SIGNIFICANT
INCREASE IN BODY WEIGHT WAS NOTED

Source text for Eikon:  ID:nMFN3DhzB2 
Further company coverage:  COMBI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Larkberget AB

See all news